Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

• Tatjana Welzel,
• Carolyn Winskill,
• Nancy Zhang,
• Andreas Woerner,
• Marc Pfister

Affiliations

Tatjana Welzel

Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel (UKBB), University of Basel

Carolyn Winskill

Integrated Drug Development, Certara LP

Nancy Zhang

Integrated Drug Development, Certara LP

Andreas Woerner

Paediatric Rheumatology, University Children’s Hospital Basel (UKBB), University of Basel

Marc Pfister

Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel (UKBB), University of Basel